A novel dithranol formulation (Micanol): The effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in Psoriasis vulgaris

Acta Dermato-Venereologica

Volumn 76, Issue 5, 1996, Pages 387-391

  Van Der Vleuten, C J M ^a   Gerritsen, M J P ^a   De Jong, E M G J ^a   Elbers, M ^a   De Jongh, G J ^a   Van De Kerkhof, P C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Crystalline monoglycerides; Immunohistochemistry; Low irritancy; Synergistic effects

Indexed keywords

DITHRANOL; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSORIASIS VULGARIS; SKIN INFLAMMATION; ULTRAVIOLET B RADIATION;

ADULT; AGED; ANTHRALIN; CAPSULES; CELL DIFFERENTIATION; CELL DIVISION; EPIDERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE AGED; OINTMENTS; PSORIASIS; SKIN; ULTRAVIOLET THERAPY;

EID: 0029848032     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Christensen OB, Brolund L. Clinical studies with a novel dithranol formulation (Micanol) in combination with UVB at day-care centres. Acta Derm Venereol (Stockh) 1992; 172: (Suppl) 17-19.
2. van der Vleuten C, de Jong E, van de Kerkhof PCM. Epidermal differentiation chareteristics of the psoriatic plaque during treatment with calcipotriol. Arch Dermatol Res 1996, in press.
3. van Duijnhoven JL, Schalkwijk J, Kranenborg MH, van Vlijmen Willems IM, Groeneveld A, van Erp PE, et al. MON 150, a versatile monoclonal antibody against involucrin: characterization and applications. Arch Dermatol Res 1992; 284: 167-172.
4. van Vlijmen Willems I, van Erp P. Microwave irradiation for rapid and enhanced immunohistochemical staining: application to skin antigens. Biotech Histochem 1993; 68: 67-74.
5. de Jong E, van de Kerkhof PCM. Short contact dithranol treatments of psoriasis, using a novel emulsifying ointment (Hermal AW). Eur J Dermatol 1992; 2: 552-559.
6. Braun Falco O, Burg G, Schoefinius HH. Über die wirkung von Dithranol (Cignolin) bei Psoriasis vulgaris. Br J Dermatol 1971; 241: 217-236.
7. Gerritsen MJ, Boezeman JB, van Vlijmen Willems IM, van de Kerkhof PCM. The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Br J Dermatol 1994; 131: 57-63.
8. Gerritsen MJ, Rulo HF, Van Vlijmen Willems I, van Erp PE, van de Kerkhof PCM. Topical treatment of psoriatic plaques with 1,25-dihydroxyvitamin D3: a cell biological study. Br J Dermatol 1993; 128: 666-673.
9. Gerritsen MJ, van Vlijmen Willems IM, Chang A, van de Kerkhof PCM. The effect of a hydrocolloid occlusive dressing (DuoDERM E) on keratinization in psoriasis vulgaris [letter]. Acta Derm Venereol (Stockh) 1994; 74: 483-484.
10. Honigsmann H. Phototherapy and photochemotherapy. Semin Dermatol 1990; 9: 84-90.
11. van de Kerkhof PCM. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br J Dermatol 1995; 132: 675-682.
12. Kemeny L, Ruzicka T, Braun Falco O. Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol 1990; 3: 1-20.
13. Schaltegger A, Brunner F, Steiger W, Krebs A. Dithranol: further investigations on the structure-activity-relationship. The new series of the 10-mono-alkyldithranol derivatives. Dermatologica 1987; 175: 136-141.
14. Lebwohl M, Berman B, France DS. Addition of short-contact anthralin therapy to an ultraviolet B phototherapy regimen: assessment of efficacy. J Am Acad Dermatol 1985; 13: 780-784.
15. Elbracht C, Landes E. [Study on the efficacy of a combined treatment of psoriasis with dithranol and UV-B (selective ultraviolet-phototherapy)]. Z Hautkr 1983; 58: 387-397.
16. Larkö O, Swanbeck G. Psoriasis treatment and a day-care centre: clinical aspects and an attempt at a cost-benefit analysis. Acta Derm Venereol (Stockh) 1982; 62: 413-418.
17. Brandt H. Ditrastick combined with UVB. An alternative regimen for plaque psoriasis. Acta Derm Venereol (Suppl) (Stockh) 1989; 146: 102-103.
18. Boer J, Smeenk G. Effect of short-contact anthralin therapy on ultraviolet B irradiation of psoriasis. J Am Acad Dermatol 1986; 15: 198-204.
19. Raab W, Gmeiner B. Influence of ultraviolet light, various temperatures, and zinc ions on anthralin (dithranol). Dermatologica 1975; 150: 267-276.
20. van de Kerkhof PCM. Dithranol treatment for psoriasis: after 75 years still going strong! Eur J Dermatol 1991; 1: 79-88.
21. van der Vleuten C, de Jong E, Rulo H, Gerritsen M, van de Kerkhof PCM. In-patient treatment with calcipotriol versus dithranol in refractory psoriasis. Eur J Dermatol 1995; 5: 676-679.
22. Paramsothy Y, Collins M, Lawrence CM. Effect of UVB therapy and a coal tar bath on short contact dithranol treatment for psoriasis. Br J Dermatol 1988; 118: 783-789.